Our | Products


LENVATIB®





THERAPEUTIC AREA: Hepatology + Rare Diseases
ACTIVE PRINCIPLE: Lenvatinib
PRESENTATION: 10 mg y 4 mg in hard capsules each
INDICATION:

  • Differentiated thyroid carcinoma

COUNTRIES WHERE IT IS MARKETED:
Argentina